TRELSTAR DEPOT

Trelstar Depot Adverse Events Reported to the FDA Over Time

How are Trelstar Depot adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Trelstar Depot, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Trelstar Depot is flagged as the suspect drug causing the adverse event.

Most Common Trelstar Depot Adverse Events Reported to the FDA

What are the most common Trelstar Depot adverse events reported to the FDA?

Headache	18 (2.62%)
Ovarian Hyperstimulation Syndrome	15 (2.18%)
Pyrexia	13 (1.89%)
Depression	11 (1.6%)
Vision Blurred	10 (1.46%)
Asthenia	9 (1.31%)
Dyspnoea	9 (1.31%)
Hypertension	9 (1.31%)
Vomiting	8 (1.16%)
Anxiety	7 (1.02%)
Arthralgia	7 (1.02%)
	Show More
Chest Pain	7 (1.02%)
Sinus Bradycardia	7 (1.02%)
Diplopia	6 (.87%)
Electrocardiogram Qt Prolonged	6 (.87%)
Haemolytic Anaemia	6 (.87%)
Oedema Peripheral	6 (.87%)
Thrombocytopenia	6 (.87%)
Anaemia	5 (.73%)
Condition Aggravated	5 (.73%)
Joint Swelling	5 (.73%)
Metrorrhagia	5 (.73%)
Nausea	5 (.73%)
Neutropenia	5 (.73%)
Pleural Effusion	5 (.73%)
Pulmonary Embolism	5 (.73%)
Suicidal Ideation	5 (.73%)
Thrombosis	5 (.73%)
Abdominal Pain	4 (.58%)
Ascites	4 (.58%)
Cerebrovascular Accident	4 (.58%)
Dizziness	4 (.58%)
Dyspareunia	4 (.58%)
Generalised Oedema	4 (.58%)
Off Label Use	4 (.58%)
Pain	4 (.58%)
Palpitations	4 (.58%)
Pathological Fracture	4 (.58%)
Renal Failure Acute	4 (.58%)
Alanine Aminotransferase Increased	3 (.44%)
Bone Pain	3 (.44%)
Cerebral Infarction	3 (.44%)
Drug Exposure During Pregnancy	3 (.44%)
Drug Hypersensitivity	3 (.44%)
Face Oedema	3 (.44%)
Foot Fracture	3 (.44%)
Hot Flush	3 (.44%)
Hypersensitivity	3 (.44%)
Hypotension	3 (.44%)
Intestinal Infarction	3 (.44%)
Liver Disorder	3 (.44%)
Mood Altered	3 (.44%)
Ovarian Enlargement	3 (.44%)
Overdose	3 (.44%)
Pain In Extremity	3 (.44%)
Papilloedema	3 (.44%)
Paraesthesia	3 (.44%)
Pelvic Fluid Collection	3 (.44%)
Pruritus	3 (.44%)
Respiratory Distress	3 (.44%)
Retinal Detachment	3 (.44%)
Suicide Attempt	3 (.44%)
Tachycardia	3 (.44%)
Urticaria	3 (.44%)
Uterine Haemorrhage	3 (.44%)
Vitamin B12 Decreased	3 (.44%)
Weight Increased	3 (.44%)
White Blood Cell Count Decreased	3 (.44%)
Acute Generalised Exanthematous Pus...	2 (.29%)
Anaemia Haemolytic Autoimmune	2 (.29%)
Anaphylactic Reaction	2 (.29%)
Angioedema	2 (.29%)
Artery Dissection	2 (.29%)
Aspartate Aminotransferase Increase...	2 (.29%)
Bacterial Infection	2 (.29%)
Blood Bilirubin Increased	2 (.29%)
Blood Folate Increased	2 (.29%)
Blood Iron Decreased	2 (.29%)
Bone Sarcoma	2 (.29%)
Cachexia	2 (.29%)
Capillary Leak Syndrome	2 (.29%)
Cardiac Failure Chronic	2 (.29%)
Cardio-respiratory Arrest	2 (.29%)
Cerebral Haemorrhage	2 (.29%)
Chills	2 (.29%)
Cross Sensitivity Reaction	2 (.29%)
Diarrhoea	2 (.29%)
Disturbance In Attention	2 (.29%)
Drug Administration Error	2 (.29%)
Dysphagia	2 (.29%)
Endometrial Cancer	2 (.29%)
Endometrial Disorder	2 (.29%)
Exophthalmos	2 (.29%)
Factor V Leiden Mutation	2 (.29%)
Fatigue	2 (.29%)
Fibromyalgia	2 (.29%)
Gastric Polyps	2 (.29%)
Granuloma	2 (.29%)
Heart Rate Increased	2 (.29%)
Hepatic Enzyme Increased	2 (.29%)
Hepatitis	2 (.29%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Trelstar Depot, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Trelstar Depot is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Trelstar Depot

What are the most common Trelstar Depot adverse events reported to the FDA?

Gastrointestinal Signs	22 (3.2%)
Vision	22 (3.2%)
Ovarian And Fallopian Tube	20 (2.91%)
Headaches	19 (2.77%)
Joint	19 (2.77%)
Epidermal And Dermal Conditions	17 (2.47%)
Neurological	16 (2.33%)
Respiratory	16 (2.33%)
Cardiac Arrhythmias	15 (2.18%)
Depressed Mood Disorders	15 (2.18%)
Hepatic And Hepatobiliary	14 (2.04%)
	Show More
Body Temperature Conditions	13 (1.89%)
Musculoskeletal And Connective Tiss...	12 (1.75%)
Vascular Hypertensive	12 (1.75%)
Central Nervous System Vascular	11 (1.6%)
Infections - Pathogen Unspecified	11 (1.6%)
Hepatobiliary	10 (1.46%)
Ocular Structural Change, Deposit A...	10 (1.46%)
Suicidal And Self-injurious Behavio...	10 (1.46%)
Uterine, Pelvic And Broad Ligament	10 (1.46%)
White Blood Cell	10 (1.46%)
Cardiac And Vascular Investigations	9 (1.31%)
Decreased And Nonspecific Blood Pre...	9 (1.31%)
Muscle	9 (1.31%)
Allergic Conditions	8 (1.16%)
Anxiety Disorders	8 (1.16%)
Embolism And Thrombosis	8 (1.16%)
Hemolyses And Related Conditions	8 (1.16%)
Menstrual Cycle And Uterine Bleedin...	8 (1.16%)
Renal Disorders	8 (1.16%)
Bacterial Infectious	7 (1.02%)
Bone And Joint Injuries	7 (1.02%)
Metabolic, Nutritional And Blood Ga...	7 (1.02%)
Peritoneal And Retroperitoneal Cond...	7 (1.02%)
Anemias Nonhemolytic And Marrow Dep...	6 (.87%)
Appetite And General Nutritional	6 (.87%)
Electrolyte And Fluid Balance Condi...	6 (.87%)
Medication Errors	6 (.87%)
Mood Disorders	6 (.87%)
Myocardial	6 (.87%)
Physical Examination Topics	6 (.87%)
Platelet	6 (.87%)
Pleural	6 (.87%)
Vascular	6 (.87%)
Angiedema And Urticaria	5 (.73%)
Gastrointestinal Vascular Condition...	5 (.73%)
Pulmonary Vascular	5 (.73%)
Bone Disorders	4 (.58%)
Cardiac Disorder Signs	4 (.58%)
Chemical Injury And Poisoning	4 (.58%)
Fractures	4 (.58%)
Gastrointestinal Motility And Defec...	4 (.58%)
Hematology Investigations	4 (.58%)
Retina, Choroid And Vitreous Hemorr...	4 (.58%)
Sexual Function And Fertility	4 (.58%)
Sleep Disorders	4 (.58%)
Therapeutic Procedures And Supporti...	4 (.58%)
Urinary Tract Signs	4 (.58%)
Vascular Inflammations	4 (.58%)
Administration Site Reactions	3 (.44%)
Benign Neoplasms Gastrointestinal	3 (.44%)
Eye	3 (.44%)
Ocular Infections, Irritations And ...	3 (.44%)
Protein And Amino Acid Metabolism	3 (.44%)
Seizures	3 (.44%)
Skin Vascular Abnormalities	3 (.44%)
Thyroid Gland	3 (.44%)
Upper Respiratory Tract Disorders	3 (.44%)
Aneurysms And Artery Dissections	2 (.29%)
Blood And Lymphatic System Disorder...	2 (.29%)
Coagulopathies And Bleeding Diathes...	2 (.29%)
Demyelinating	2 (.29%)
Endocrine Investigations	2 (.29%)
Gastrointestinal Neoplasms Malignan...	2 (.29%)
Heart Failures	2 (.29%)
Hematological	2 (.29%)
Increased Intracranial Pressure And...	2 (.29%)
Inner Ear And Viiith Cranial Nerve	2 (.29%)
Lipid Metabolism	2 (.29%)
Mental Impairment	2 (.29%)
Microbiology And Serology	2 (.29%)
Movement Disorders	2 (.29%)
Nephropathies	2 (.29%)
Obstetric And Gynecological Therape...	2 (.29%)
Ocular Neuromuscular	2 (.29%)
Oral Soft Tissue Conditions	2 (.29%)
Peripheral Neuropathies	2 (.29%)
Pregnancy, Labour, Delivery And Pos...	2 (.29%)
Procedural And Device Related Injur...	2 (.29%)
Reproductive Neoplasms Female Malig...	2 (.29%)
Skeletal Neoplasms Malignant And Un...	2 (.29%)
Therapeutic And Nontherapeutic Effe...	2 (.29%)
Viral Infectious	2 (.29%)
Water, Electrolyte And Mineral	2 (.29%)
Abortions And Stillbirth	1 (.15%)
Ancillary Infectious Topics	1 (.15%)
Breast Neoplasms Malignant And Unsp...	1 (.15%)
Central Nervous System Infections A...	1 (.15%)
Connective Tissue Disorders	1 (.15%)
Cranial Nerve Disorders	1 (.15%)
Eye Disorders Congenital	1 (.15%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Trelstar Depot, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Trelstar Depot is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.